TN HB2308 | 2023-2024 | 113th General Assembly
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on May 13 2024 - 100% progression
Action: 2024-05-13 - Comp. became Pub. Ch. 857
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on May 13 2024 - 100% progression
Action: 2024-05-13 - Comp. became Pub. Ch. 857
Text: Latest bill text (Chaptered) [PDF]
Summary
As enacted, only authorizes a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
Title
AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to the use of buprenorphine products.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-13 | Comp. became Pub. Ch. 857 | |
| 2024-04-15 | House | Comp. SB subst. |
| 2024-04-10 | House | H. Placed on Regular Calendar for 4/15/2024 |
| 2024-04-10 | House | Reset on next avail. cal. |
| 2024-04-04 | House | H. Placed on Regular Calendar for 4/10/2024 |
| 2024-04-04 | House | Reset on next avail. cal. |
| 2024-03-28 | House | H. Placed on Regular Calendar for 4/4/2024 |
| 2024-03-27 | House | Placed on cal. Calendar & Rules Committee for 3/28/2024 |
| 2024-03-20 | House | Rec. for pass. if am., ref. to Calendar & Rules Committee |
| 2024-03-13 | House | Placed on cal. Health Committee for 3/20/2024 |
| 2024-03-12 | House | Rec for pass if am by s/c ref. to Health Committee |
| 2024-03-06 | House | Placed on s/c cal Health Subcommittee for 3/12/2024 |
| 2024-02-06 | House | Assigned to s/c Health Subcommittee |
| 2024-02-01 | House | P2C, ref. to Health Committee |
| 2024-01-31 | House | Intro., P1C. |
| 2024-01-29 | House | Filed for introduction |
Same As/Similar To
SB2297 (Crossfiled) 2024-05-13 - Effective date(s) 05/01/2024
